Investigational New Drug (IND)
See the following -
Soaring Clinical Trials Costs And Effects On Drug Prices
Ryan Haake | PharmaThought | August 5, 2014
The cost to bring a new drug to market has skyrocketed over the past several decades and, in large part, is due to the rising cost of clinical trials. In 2013, Forbes magazine estimated it would cost a company over $350 million for one drug to reach patients...
- Login to post comments
Transparency Life Sciences Awarded $1.4 Million NCATS SBIR Grant To Conduct Innovative Trial Of Lisinopril In Multiple Sclerosis
Press Release |
Transparency Life Sciences |
September 8, 2014
Transparency Life Sciences, LLC (TLS)...today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive therapy for multiple sclerosis (MS).
- Login to post comments